These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11315842)

  • 1. Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy.
    Perkins BA; Greene DA; Bril V
    Diabetes Care; 2001 Apr; 24(4):748-52. PubMed ID: 11315842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy.
    Tkac I; Bril V
    Diabetes Care; 1998 Oct; 21(10):1749-52. PubMed ID: 9773742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy.
    Bril V; Perkins BA
    Diabetes Care; 2002 Nov; 25(11):2048-52. PubMed ID: 12401755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction slowing in diabetic sensorimotor polyneuropathy.
    Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Diabetes Care; 2013 Nov; 36(11):3684-90. PubMed ID: 24026550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ultrasonographic nerve morphology and severity of diabetic sensorimotor polyneuropathy.
    Arumugam T; Razali SN; Vethakkan SR; Rozalli FI; Shahrizaila N
    Eur J Neurol; 2016 Feb; 23(2):354-60. PubMed ID: 26498575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy.
    Perkins BA; Ngo M; Bril V
    Muscle Nerve; 2002 Feb; 25(2):212-7. PubMed ID: 11870689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of distal symmetric polyneuropathy during diabetes mellitus: clinical, neurophysiological, haemorheological changes and self-rating scales of patients.
    Husstedt IW; Grotemeyer KH; Evers S; Staschewski F; Wertelewski R
    Eur Neurol; 1997; 37(2):90-4. PubMed ID: 9058063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
    Perkins BA; Grewal J; Ng E; Ngo M; Bril V
    Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    J Neurol Sci; 2017 Aug; 379():94-98. PubMed ID: 28716288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes.
    Nabavi Nouri M; Ahmed A; Bril V; Orszag A; Ng E; Nwe P; Perkins BA
    PLoS One; 2012; 7(4):e34807. PubMed ID: 22529938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diabetic polyneuropathy. II. Polyneuropathy, angiopathy and nerve conduction velocity].
    Fischer W; Reichel G; Rabending G; Bruns W; Haubenreiser H; Sodemann K; Zander G
    Endokrinologie; 1979; 74(2):221-32. PubMed ID: 535579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total antioxidant blood capacity in patients with type 2 diabetes mellitus and distal symmetrical polyneuropathy].
    Dordević G; Durić S; Apostolskit S; Dordević V; Zivković M
    Vojnosanit Pregl; 2008 Sep; 65(9):663-9. PubMed ID: 18814501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local human sural nerve blood flow in diabetic and other polyneuropathies.
    Theriault M; Dort J; Sutherland G; Zochodne DW
    Brain; 1997 Jul; 120 ( Pt 7)():1131-8. PubMed ID: 9236626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma norepinephrine in sensory diabetic polyneuropathy.
    Tsigos C; Reed P; Weinkove C; White A; Young RJ
    Diabetes Care; 1993 May; 16(5):722-7. PubMed ID: 8495611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients?
    Breiner A; Lovblom LE; Perkins BA; Bril V
    Diabetes Care; 2014 May; 37(5):1418-24. PubMed ID: 24574353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.
    Valensi P; Giroux C; Seeboth-Ghalayini B; Attali JR
    J Diabetes Complications; 1997; 11(1):27-34. PubMed ID: 9025010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes.
    Orlov S; Bril V; Orszag A; Perkins BA
    Diabetes Care; 2012 Apr; 35(4):809-16. PubMed ID: 22357183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.
    Weisman A; Bril V; Ngo M; Lovblom LE; Halpern EM; Orszag A; Perkins BA
    PLoS One; 2013; 8(3):e58783. PubMed ID: 23533591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.
    Bril V; Buchanan RA
    Diabetes Care; 2004 Oct; 27(10):2369-75. PubMed ID: 15451902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between diabetic complications and exercise capacity in NIDDM patients.
    Estacio RO; Regensteiner JG; Wolfel EE; Jeffers B; Dickenson M; Schrier RW
    Diabetes Care; 1998 Feb; 21(2):291-5. PubMed ID: 9539998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.